Cardiomyopathy

Heart diseases can take on various forms one of which is cardiomyopathy. JMC stem cell therapy can be used for treating patients for different kinds of cardiomyopathy. It can provide relief from various symptoms associated with this condition. However, it is important to understand which types of cardiomyopathy can be treated with adult stem cell therapy as cardiomyopathy is a broad category of heart diseases.

What is Cardiomyopathy?

In simple terms, cardiomyopathy can be described as a heart disease. In this condition, the muscles of the heart begin to degenerate leading to a decrease in performance and loss of function in some cases. Some of the potential factors that can lead to cardiomyopathy are given below.

General Symptoms of Cardiomyopathy

Some patients of cardiomyopathy can function normally and do not have any symptoms. Nonetheless, there is a risk of a sudden and severe cardiac event. Some common symptoms of this condition are given below.

As the condition worsens, the heart will progressively become weaker. It will not be able to maintain a consistent rhythm. At this stage, arrhythmia will develop along with issues in the heart valves. It is also possible for the complications to worsen further and cause heart failure.

Types of Cardiomyopathy

The problem with cardiomyopathy is that it is difficult to prescribe a course of action. Prognosis of the disease is completely dependent on the medical history of the patient as well as the specific kind of cardiomyopathy.

Dilated Cardiomyopathy: The hearts of these patients will become enlarged which leads to inefficient performance of the organ. This type of cardiomyopathy can be caused by a variety of factors including viruses and defective aortic valve.

Ischemic Cardiomyopathy: In ischemia, the blood is unable to flow to the heart. This causes the heart to become weak and enlarged. This condition is common among patients who had heart attacks or are suffering from coronary artery disease. Ischemic cardiomyopathy is considered to be a version of dilated cardiomyopathy.

Hypertrophic Cardiomyopathy: It is often called obstructive cardiomyopathy. This condition is genetic in nature and can be passed down the family tree. In this condition, the outflow capacity of the heart is reduced by the hardening of the heart muscles.

Helping Cardiomyopathy Patients with Stem Cell Therapy

JMC stem cell therapy has been noticed to be quite effective at reducing and repairing the damage of the heart. It can also help the heart recover its functions. The benefits are made possible through the use of a special kind of stem cell which is derived from the fatty tissues of the patient.

Clinical trials have shown that stem cell therapies can bring major benefits to those suffering from ischemic cardiomyopathy. However, it is not yet clear whether the treatment can be used for other types of cardiomyopathy. Patients suffering from ischemic cardiomyopathy have shown improvements using treatment models similar to the one used in JMC stem cell therapy. Doctors will analyze each case individually to determine if the patient will be benefitted from JMC stem cell therapy.